Trials / Completed
CompletedNCT02365298
Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact Lenses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
In vitro studies show that some hydrogel materials uptake more lysozyme than other hydrogel materials and that this protein remains largely active and promotes reduced cytokine response in an in vitro culture of human corneal epithelial cells. This study investigates whether these data transfer to the in vivo situation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | etafilcon A | etafilcon A soft contact lens |
| DEVICE | nelfilcon A | nelfilcon A |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2015-02-18
- Last updated
- 2018-06-19
- Results posted
- 2017-07-13
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02365298. Inclusion in this directory is not an endorsement.